http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004099147-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ddbcff76e4982d113dbb866c8a494f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_65f6765a6f0387cfcb75bc6a09213161
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
filingDate 2004-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44dba4caa06a59af83c4377607d074a6
publicationDate 2004-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2004099147-A1
titleOfInvention Intermediate compound which is used for the preparation of pioglitazone
abstract The invention relates to a compound having formula (IV), which is an intermediate compound that is used for the preparation of pioglitazone. The invention also relates to a method of obtaining the novel compound (IV) from a natural product, L-tyrosine, in which the amino group, in the form of an imino-aromatic group, is protected. The invention further relates to a method of obtaining pioglitazone from the aforementioned intermediate compound.
priorityDate 2003-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000344748-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08325263-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4687777-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02088120-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53942694
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408767182
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID29010894
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11381457
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58854909
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1153
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447599602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394197
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128240590
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11770247
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128244086
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26650
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465494543
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420880413

Total number of triples: 40.